Top of the morning to you. Once again, a shiny sun is hovering overhead as we begin another busy day here on the Pharmalot corporate campus. So without further ado, we will get on with the task of pursuing interesting items. Meanwhile, please join us as we tank up with another cup of stimulation. Perhaps the buzz will do you some good, too. And here, of course, are a few tidbits to help your day get started. Hope all goes well and you accomplish much. Stay in touch...
Pfizer And Mylan To Develop And Market Drugs In Japan (RTT News)
Pfizer Ad Campaign Emphasizes The Turnstiles Of Life (Adweek)
Childhood Cancer Patients At Greater Risk Of Diabetes: Study (Bloomberg News)
Glenmark Wins Right To Sell HIV Diarrhea Drug In 140 Countries (Reuters)
Father's Age Linked To Risk Of Autism And Schizophrenia (New York Times)
United Drug Wants Suit Over Catalent Charges Tossed (Outsourcing Pharma)
Pfizer Seeks To End Fen-Phen Lawsuits Tied To Lung Disease (Bloomberg News)
Xoma Wins Orphan Status For Eye Disease Med (San Francisco Business Journal)
Venezuela Moves To Toughen Pharma Import Process (Pharma Times)
Greek Drugmakers Unhappy Over Pricing Policy (Cyprus Mail)
EDITOR'S NOTE: Please check this post for updates during the day
steaming coffee pic thx to dleggett on flickr






6 Comments
So many business development opportunities, so little time.
Ed, do you know where to find what NIH published? - Huff and Post is not classic journalism :-)
FOI request for details, I guess...?
I keep coming up with more and more questions on this one - and that is not a good thing.